Walmart Set to Join Nasdaq-100 Index, Replacing AstraZeneca from January 20
Walmart is scheduled to join the Nasdaq-100 index, replacing AstraZeneca effective January 20. This reshuffle represents a significant change in the composition of the major US stock market benchmark. The modification will require institutional investors and fund managers tracking the index to rebalance their portfolios accordingly.

*this image is generated using AI for illustrative purposes only.
Walmart is set to join the Nasdaq-100 index in a significant reshuffle of the major US stock market benchmark. The retail giant will replace AstraZeneca, with the change scheduled to take effect from January 20.
Index Composition Change
The upcoming modification to the Nasdaq-100 represents a notable shift in the index's composition. The following table outlines the key details of this reshuffle:
| Parameter: | Details |
|---|---|
| Incoming Company: | Walmart |
| Outgoing Company: | AstraZeneca |
| Effective Date: | January 20 |
| Index: | Nasdaq-100 |
Significance of the Reshuffle
The Nasdaq-100 is one of the most closely monitored stock market indices, serving as a benchmark for technology and growth-oriented companies. Index changes like this typically reflect shifts in market capitalization, trading volume, and other criteria that determine index eligibility.
Walmart's inclusion in the Nasdaq-100 marks the entry of one of the world's largest retail corporations into this prominent index. The change will likely impact index funds and exchange-traded funds that track the Nasdaq-100, as fund managers will need to adjust their holdings accordingly.
Market Impact
This reshuffle will require institutional investors and fund managers who track the Nasdaq-100 to rebalance their portfolios. The change involves removing AstraZeneca from their holdings and adding Walmart shares to maintain alignment with the updated index composition.
The timing of the change, set for January 20, provides market participants with advance notice to prepare for the necessary portfolio adjustments and trading activities associated with the index modification.



























